16 results on '"Ryota Kosaki"'
Search Results
2. Diagnostic Performance of Noninvasive Computed Tomography–Derived Fractional Flow Reserve in Patients With Severe Aortic Stenosis
- Author
-
Futoshi Yamanaka, Koki Shishido, Noriaki Moriyama, Tomoki Ochiai, Daisuke Sato, Eiji Koyama, Yoichi Sugiyama, Yusuke Tamaki, Takashi Yamada, Takahiro Hayashi, Hirokazu Miyashita, Hiroaki Yokoyama, Ryota Kosaki, Takayoshi Yamashita, Masashi Yamaguchi, Tamiharu Yamagishi, Takashi Matsumoto, Kazuki Tobita, Shingo Mizuno, Yutaka Tanaka, Masato Murakami, Saeko Takahashi, Kenichi Tsujita, and Shigeru Saito
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2023
3. Early Vascular Healing Following Bioresorbable-Polymer Sirolimus-Eluting Stent Placement Compared to That with Durable-Polymer Everolimus-Eluting Stent
- Author
-
Koshiro Sakai, Ryota Masaki, Myong Hwa Yamamoto, Yosuke Oishi, Shunya Sato, Hiroshi Suzuki, Toshiro Shinke, Ken Arai, Masahiko Ochiai, Rikuo Sakai, Kosuke Nomura, Kohei Wakabayashi, Kunihiro Ogura, Hiroaki Tsujita, Teruo Sekimoto, Ryota Kosaki, Hidenari Matsumoto, Taito Arai, Shigeto Tsukamoto, Naoki Matsukawa, Seita Kondo, Hideaki Tanaka, and Hiroyoshi Mori
- Subjects
business.industry ,medicine.medical_treatment ,Everolimus eluting stent ,Stent ,Percutaneous coronary intervention ,General Medicine ,equipment and supplies ,Vascular healing ,Stent placement ,surgical procedures, operative ,Drug-eluting stent ,Sirolimus ,Conventional PCI ,Medicine ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,business ,Nuclear medicine ,medicine.drug - Abstract
A recent thinner strut drug-eluting stent might facilitate early strut coverage after its placement. We aimed to investigate early vascular healing responses after the placement of an ultrathin-strut bioresorbable-polymer sirolimus-eluting stent (BP-SES) compared to those with a durable-polymer everolimus-eluting stent (DP-EES) using optical coherence tomography (OCT) imaging.This study included 40 patients with chronic coronary syndrome (CCS) who underwent OCT-guided percutaneous coronary intervention (PCI). Twenty patients each received either BP-SES or DP-EES implantation. OCT was performed immediately after stent placement (baseline) and at 1-month follow-up.At one month, the percentage of uncovered struts reduced significantly in both the BP-SES (80.9 ± 10.3% to 2.9 ± 1.7%; P < 0.001) and DP-EES (81.9 ± 13.0% to 5.7 ± 1.8%; P < 0.001) groups, and the percentage was lower in the BP-SES group than in the DP-EES group (P < 0.001). In the BP-SES group, the percentage of malapposed struts also decreased significantly at 1 month (4.9 ± 3.7% to 2.6 ± 3.0%; P = 0.025), which was comparable to that of the DP-EES group (2.5 ± 2.2%; P = 0.860). The optimal cut-off value of the distance between the strut and vessel surface immediately after the placement to predict resolved malapposed struts was ≤ 160 μm for BP-SES and ≤ 190 μm for DP-EES.Compared to DP-EES, ultrathin-strut BP-SES demonstrated favorable vascular responses at one month, with a lower rate of uncovered struts and a comparable rate of malapposed struts.
- Published
- 2021
4. Early Vascular Response to Ultrathin Biodegradable Polymer Sirolimus-Eluting Stents for the Treatment of ST-Elevation Myocardial Infarction After Plaque Rupture
- Author
-
Syunya Sato, Koshiro Sakai, Taito Arai, Hiroyoshi Mori, Hidenari Matsumoto, Ryota Masaki, Hiroaki Tsujita, Naoki Matsukawa, Ryota Kosaki, Ken Arai, Kohei Wakabayashi, Kunihiro Ogura, Yosuke Oishi, Shigeto Tsukamoto, Teruo Sekimoto, Hiroshi Suzuki, Toshiro Shinke, Seita Kondo, Hideaki Tanaka, Rikuo Sakai, Masahiko Ochiai, Myong Hwa Yamamoto, and Kosuke Nomura
- Subjects
Male ,medicine.medical_specialty ,Acute coronary syndrome ,medicine.medical_treatment ,Lumen (anatomy) ,Pilot Projects ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Coronary Circulation ,Internal medicine ,medicine ,Humans ,Prospective Studies ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Aged ,Sirolimus ,Antibiotics, Antineoplastic ,medicine.diagnostic_test ,business.industry ,Percutaneous coronary intervention ,Stent ,Drug-Eluting Stents ,General Medicine ,Middle Aged ,equipment and supplies ,medicine.disease ,Coronary Vessels ,Apposition ,Treatment Outcome ,surgical procedures, operative ,Angiography ,Conventional PCI ,Cardiology ,ST Elevation Myocardial Infarction ,Female ,Cardiology and Cardiovascular Medicine ,business ,Tomography, Optical Coherence - Abstract
Recent clinical studies suggest that newer-generation drug-eluting stents that combine ultrathin struts and nanocoating (biodegradable polymer sirolimus-eluting stents, BP-SES) could improve long-term clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). However, the early vascular response to BP-SES in these patients has not been investigated so far.We examined this response in 20 patients with STEMI caused by plaque rupture using frequency-domain optical coherence tomography (OCT) to understand the underlying mechanisms. Plaque rupture was diagnosed by OCT before PCI with BP-SES implantation was performed. OCT was again performed before the final angiography (post-PCI) and after 2 weeks (2W-OCT).BP-SES placement caused protrusion of atherothrombotic material into the stent lumen and incomplete stent apposition in all patients. After 2 weeks, incomplete stent apposition was significantly reduced (% malapposed struts: post-PCI 4.7 ± 3.3%; 2W-OCT 0.9 ± 1.2%; P < 0.0001), and the percentage of uncovered struts also significantly decreased (% uncovered struts: post-PCI; 69.8 ± 18.3%: 2W-OCT; 29.6 ± 11.0%, P < 0.0001). The maximum protrusion area of the atherothrombotic burden was significantly reduced (post-PCI 1.36 ± 0.70 mm2; 2W-OCT 0.98 ± 0.55 mm2; P = 0.004).This study on the early vascular responses following BP-SES implantation showed rapid resolution of atherothrombotic material and progression of strut apposition and coverage. (UMIN000041324).
- Published
- 2021
5. Large Right Pulmonary Vein Is a Predictor of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation in Patients with Persistent Atrial Fibrillation
- Author
-
Hiroto Fukuoka, Takahiro Furuya, Rumi Hachiya, Naoko Ikeda, Kaoru Tanno, Toshiaki Suzuki, Fumito Miyoshi, Tenjin Nishikura, Chisato Sato, Miwa Kikuchi, Ryota Kosaki, Kohei Wakabayashi, Naoki Aizawa, Keita Shibata, Mitsuyuki Morimura, and Masahiko Izumizaki
- Subjects
medicine.medical_specialty ,Electroanatomic mapping ,Isolation (health care) ,business.industry ,Atrial fibrillation ,medicine.disease ,Pulmonary vein ,Right pulmonary vein ,Internal medicine ,Persistent atrial fibrillation ,Cardiology ,medicine ,In patient ,business - Published
- 2020
6. Onset time and prognostic value of acute kidney injury in patients with acute myocardial infarction
- Author
-
Shinji Koba, Kaoru Tanno, Kosuke Nomura, Shunya Sato, Ken Arai, Yosuke Oishi, Koshiro Sakai, Shigeto Tsukamoto, Teruo Sekimoto, Ryota Kosaki, Hiroaki Tsujita, Kohei Wakabayashi, Kunihiro Ogura, Tenjin Nishikura, Seita Kondo, Toshiro Shinke, and Hideaki Tanaka
- Subjects
medicine.medical_specialty ,Percutaneous ,Percutaneous coronary interventions ,030204 cardiovascular system & hematology ,urologic and male genital diseases ,03 medical and health sciences ,0302 clinical medicine ,Late phase ,Intensive care ,Internal medicine ,medicine ,Clinical endpoint ,Diseases of the circulatory (Cardiovascular) system ,In patient ,030212 general & internal medicine ,Myocardial infarction ,cardiovascular diseases ,Mortality ,Original Paper ,business.industry ,urogenital system ,Acute kidney injury ,Mean age ,medicine.disease ,female genital diseases and pregnancy complications ,Serum creatinine ,RC666-701 ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Acute myocardial infraction - Abstract
Highlights • Even small declines in renal function are associated with worse short-term outcomes after AMI. • The clinical impact of the timing of acute kidney injury (AKI) onset after AMI is unknown. • Early-phase AKI is associated with poor long-term mortality. • Late-phase AKI is not associated with poor long-term mortality. • Careful clinical attention and intensive care should be used in patients with early-phase AKI after AMI., Background The mechanisms and clinical impact of acute kidney injury (AKI) after acute myocardial infarction (AMI) may differ depending on whether AKI develops during the early or late phase after AMI. The present study assessed the timing of AKI onset and the prognostic impact on long-term outcomes in patients hospitalized with AMI. Methods The present study enrolled consecutive AMI survivors who had undergone successful percutaneous coronary interventions at admission. AKI was defined as an increase in the serum creatinine level of ≥0.3 mg/dL above the admission value within 7 days of hospitalization. AKI patients were further divided into two subgroups (early-phase AKI: within 3 days vs. late-phase AKI: 4 to 7 days after AMI onset). The primary endpoint was all-cause death. Results In total, 506 patients were included in this study, with 385 men and a mean age of 69.5 ± 13.5 years old. The mean follow-up duration was 1289.5 ± 902.8 days. AKI developed in 127 patients (25.1%). Long-term mortality was significantly higher in the AKI group than in the non-AKI group (log-rank p
- Published
- 2021
7. Ultra-minimum contrast percutaneous coronary intervention for a patient with complex coronary artery disease and end-stage diabetic nephropathy
- Author
-
Kaoru Tanno, Keita Shibata, Tenjin Nishikura, Ryota Kosaki, Chisato Sato, Toshiro Shinke, and Kohei Wakabayashi
- Subjects
medicine.medical_specialty ,Ischemic cardiomyopathy ,business.industry ,medicine.medical_treatment ,Percutaneous coronary intervention ,Case Report ,030204 cardiovascular system & hematology ,medicine.disease ,Revascularization ,Nephropathy ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Heart failure ,Conventional PCI ,medicine ,Cardiology ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business ,Kidney disease - Abstract
A pivotal trial indicated that an initial invasive strategy did not improve the clinical outcomes in patients with moderate or severe ischemic heart disease and advanced chronic kidney disease (CKD) as compared with an initial conservative strategy. It is well known that contrast-induced nephropathy (CIN) is associated with worse prognosis after percutaneous coronary intervention (PCI). Minimum contrast PCI may lower the risk of CIN and improve the clinical outcomes of ischemic heart disease and advanced CKD. Here we report a case involving a 46-year-old woman with ischemic cardiomyopathy who was scheduled to start hemodialysis for end-stage diabetic nephropathy but exhibited improved renal function in accordance with the left ventricular function after PCI with an extremely low contrast dose. Accordingly, dialysis was not performed, and the patient did not require it for >2 years after coronary revascularization. The present case supports aggressive examination and revascularization for severe heart failure with an extremely low amount of contrast, even if the patient has complex coronary lesions and end-stage CKD.
- Published
- 2021
8. Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome
- Author
-
Ryota Masaki, Yuya Yokota, Yosuke Oishi, Ryota Kosaki, Taito Arai, Teruo Sekimoto, Koshiro Sakai, Ken Arai, Rikuo Sakai, Shinji Koba, Kosuke Nomura, Yuji Hamazaki, Shunya Sato, Fumiyoshi Tsunoda, Makoto Shoji, Kunihiro Ogura, Seita Kondo, Shigeto Tsukamoto, Hideaki Tanaka, Toshiro Shinke, Hiroaki Tsujita, Hiroyoshi Mori, and Hidenari Matsumoto
- Subjects
Male ,Acute coronary syndrome ,medicine.medical_specialty ,medicine.medical_treatment ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Culprit ,Triglyceride ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Myocardial infarction ,Stroke ,Small dense low-density lipoprotein cholesterol ,Aged ,business.industry ,Biochemistry (medical) ,Rapid progression ,Percutaneous coronary intervention ,Cholesterol, LDL ,Middle Aged ,medicine.disease ,Prognosis ,Coronary Vessels ,Stenosis ,Cardiology ,Apolipoprotein C3 ,lipids (amino acids, peptides, and proteins) ,Female ,Original Article ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery ,Biomarkers ,Follow-Up Studies - Abstract
Aim: This study investigated whether the small dense low-density lipoprotein cholesterol (sd-LDL-c) level is associated with the rapid progression (RP) of non-culprit coronary artery lesions and cardiovascular events (CE) after acute coronary syndrome (ACS). Methods: In 142 consecutive patients with ACS who underwent primary percutaneous coronary intervention for the culprit lesion, the sd-LDL-c level was measured using a direct homogeneous assay on admission for ACS and at the 10-month follow-up coronary angiography. RP was defined as a progression of any pre-existing coronary stenosis and/or stenosis development in the initially normal coronary artery. CEs were defined as cardiac death, myocardial infarction, stroke, or coronary revascularization. Results: Patients were divided into two groups based on the presence ( n =29) or absence ( n =113) of RP after 10 months. The LDL-c and sd-LDL-c levels at baseline were equivalent in both the groups. However, the sd-LDL-c, triglyceride, remnant lipoprotein cholesterol (RL-c), and apoC3 levels at follow-up were significantly higher in the RP group than in the non-RP group. The optimal threshold values of sd-LDL-c, triglyceride, RL-c, and apoC3 for predicting RP according to receiver operating characteristics analysis were 20.9, 113, 5.5, and 9.7 mg/dL, respectively. Only the sd-LDL-c level (≥ 20.9 mg/dL) was significantly associated with incident CEs at 31±17 months (log-rank: 4.123, p =0.043). Conclusions: The sd-LDL-c level on treatment was significantly associated with RP of non-culprit lesions, resulting in CEs in ACS patients. On-treatment sd-LDL-c is a residual risk and aggressive reduction of sd-LDL-c might be needed to prevent CEs.
- Published
- 2021
9. Early vascular responses to ultrathin biodegradable polymer sirolimus-eluting stent for the treatment of st-elevation myocardial infarction
- Author
-
Kosuke Nomura, Hidenari Matsumoto, Hiroyoshi Mori, Kunihiro Ogura, Yosuke Oishi, Hiroaki Tsujita, Shigeto Tsukamoto, Ken Arai, Koshiro Sakai, Teruo Sekimoto, Ryota Masaki, Seita Kondo, Hideaki Tanaka, Toshiro Shinke, and Ryota Kosaki
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Stent ,medicine.disease ,Biodegradable polymer ,St elevation myocardial infarction ,Internal medicine ,Sirolimus ,medicine ,Cardiology ,Thrombus ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Background Recent clinical study suggests newer-generation drug-eluting stents (DES) that combine ultrathin strut and nano-coating with biodegradable polymers sirolimus-eluting stent (BP-SES) could improve long-term clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) over current generation DES. However, safety profiles in very early phase have not been systematically addressed. Objective and method We exploratory investigate early vascular response following BP-SES implantation in patients with STEMI to reveal mechanism of the favorable clinical outcomes in recent studies using frequency domain-optical coherence tomography (FD-OCT). Consecutive twenty patients with STEMI who underwent FD-OCT immediately after primary PCI and were eligible for follow-up FD-OCT at 2 weeks after implantation were enrolled between June 2018 and November 2019. Results Twenty patients (age 62.7±11.3 years, male 85.0%) were enrolled with frequencies of hypertension (45.0%), diabetes mellitus (35.0%), dyslipidemia (55.0%) and smoking (80.0%). Aspiration catheter were used in all patients, and 1.13±0.34 stents were used. Only one patient (5.0%) received chronic antiplatelet therapy with aspirin prior to the onset of STEMI. All patients started to receive prasugrel as thienopyridine from this event and continued dual antiplatelet therapy for 2 weeks. The percentage of uncovered struts significantly decreased from post-procedure to 2W follow-up (69±18% post-procedure versus 30±11% at 2W follow up, p Conclusion(s) This study firstly elucidated very early vascular responses following ultrathin strut BP-SES implantation in STEMI patients, showing early progression of strut coverage and resolution of athero-thrombotic materials. This technology may have a potential to overcome the current generation DESs in this clinical setting. Thrombus, uncovered and malapposed struts Funding Acknowledgement Type of funding source: None
- Published
- 2020
10. Safety and efficacy of a hyperaemic agent, intracoronary nicorandil 4mg, for invasive physiological assessments during fractional flow reserve measurement
- Author
-
Takahiro Furuya, Kaoru Tanno, Naoko Ikeda, Tenjin Nishikura, Kohei Wakabayashi, Miwa Kikuchi, Ryota Kosaki, Toshiaki Suzuki, N Aizawa, Keita Shibata, Hiroto Fukuoka, and Fumito Miyoshi
- Subjects
medicine.medical_specialty ,Steady state (electronics) ,business.industry ,Coronary arteriosclerosis ,Fractional flow reserve ,Chest pain ,medicine.disease ,Adenosine ,Internal medicine ,cardiovascular system ,medicine ,Cardiology ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Intracoronary route ,business ,Nicorandil ,Atrioventricular block ,medicine.drug - Abstract
Background Fractional flow reserve (FFR) is one of most reliable index for the determining the functional severity coronary artery stenosis. Adenosine is the most commonly used agent for maximal hyperaemia. However, adenosine can cause chest discomfort, bronchial hyper-reactivity, and atrioventricular block. The aim of this study is to evaluate the safety and efficacy of intracoronary nicorandil as an alternative hyperaemic agent for FFR. Methods and results We enrolled consecutive 82 patients (87 lesions) who underwent FFR measurement in our center from Nov. 2018. We compared three groups; intravenous infusion of adenosine (150 μg/kg/min); and adenosine added intracoronary nicorandil 2mg; and intracoronary nicorandil 4mg. Mean FFR value was 0.83±0.09, 0.82±0.09, 0.82±0.08, There was a strong correlation among three groups (R2>0.9). Mean cyclic change in FFR was 0.026±0.023, 0.019±0.010, 0.016±0.014, respectively, cyclic change was smallest in intracoronary nicorandil 4mg group (vs ATP; p Conclusions Intracoronary nicorandil 4mg is a simple, safe, and effective way to induce steady-state hyperaemia for FFR. Figure 1 Funding Acknowledgement Type of funding source: None
- Published
- 2020
11. Thrombomodulin can Predict the Incidence of Second Events in Patients with Acute Myocardial Infarction
- Author
-
Ryota KOSAKI, Yoshino MINOURA, Kosuke NOMURA, Koshiro SAKAI, Teruo SEKIMOTO, Tenjin NISHIKURA, Satoshi HOSOKAWA, Hiroaki TSUJITA, Seita KONDO, Shigeto TSUKAMOTO, Mitsunori MUTO, Yuji HAMAZAKI, and Youichi KOBAYASHI
- Subjects
medicine.medical_specialty ,business.industry ,Incidence (epidemiology) ,Internal medicine ,medicine ,Cardiology ,In patient ,Myocardial infarction ,medicine.disease ,Thrombomodulin ,business - Published
- 2017
12. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study
- Author
-
Yoshino Minoura, Koshiro Sakai, Yosuke Oishi, Ken Arai, Teruo Sekimoto, Kosuke Nomura, Ryota Kosaki, Hiroaki Tsujita, Tenjin Nisikura, Kunihiro Ogura, Shigeto Tsukamoto, Yuji Hamazaki, Seita Kondo, Lisa Tanaka, and Youichi Kobayashi
- Subjects
Male ,Acute coronary syndrome ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Thrombomodulin ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,03 medical and health sciences ,0302 clinical medicine ,Percutaneous Coronary Intervention ,Postoperative Complications ,Internal medicine ,Angioplasty ,Natriuretic Peptide, Brain ,Plasminogen Activator Inhibitor 1 ,medicine ,Odds Ratio ,Humans ,cardiovascular diseases ,030212 general & internal medicine ,Postoperative Period ,Acute Coronary Syndrome ,Angioplasty, Balloon, Coronary ,Aged ,Retrospective Studies ,Ejection fraction ,business.industry ,Incidence ,Percutaneous coronary intervention ,Retrospective cohort study ,Heart ,Odds ratio ,Middle Aged ,medicine.disease ,Brain natriuretic peptide ,Peptide Fragments ,C-Reactive Protein ,Cardiovascular Diseases ,Conventional PCI ,Cardiology ,Female ,Prothrombin ,Stents ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers - Abstract
Plasma levels of atherothrombosis-related markers such as endothelial biomarkers have been reported to predict the risk of first acute coronary syndrome (ACS) events. Percutaneous coronary intervention (PCI) by balloon angioplasty and stenting established as a treatment for ACS enabled early discharge and early clinic care. The procedure of PCI, however, may itself be associated with arterial injury with endothelial dysfunction. The clinical significance of those biomarkers for second events in patients after PCI has not yet been completely understood to identify patients who need strict follow-up.After the exclusion of 100 patients (60 deaths during hospitalization, 40 severe renal failure), 400 ACS patients (291 males, 71.1±13.0 years) who had undergone successful PCI followed by biomarker assessment within the first postoperative hour were enrolled. We evaluated atherothrombosis-related biomarkers: thrombomodulin (TM), C-reactive protein (CRP), and D-dimer, prothrombin fragment F1+2, and plasminogen activator inhibitor-1, other than those assessed by routine biochemical tests. The outcome after PCI in ACS patients was assessed by the incidence of major adverse cardiovascular events (MACEs).MACEs occurred in 112 patients during the follow-up period (813.9±474.8 days). As in previous reports, patients with MACEs showed decreased left ventricular ejection fraction (LVEF) by echocardiography, elevated brain natriuretic peptide and HbA1c than patients without MACEs. Not only these markers but also TM were significantly associated with MACEs in multivariate analysis. There were no significant correlations between MACEs and CRP. The association between TM and MACEs was especially high (odds ratio 2.73) and unaffected by the stage of cardiac (≤40, 40LVEF≤55, 55%) or renal function (≤40, 40creatinine clearance≤75, 75ml/min).TM is independently associated with MACEs and may be predictive of second events in patients after PCI for ACS. ACS patients with high TM value need strict follow up.
- Published
- 2018
13. Monitoring Serum Creatinine during the First Week after Myocardial Infarction May Help to Identify Patients Who Are at Highest Risk
- Author
-
Seita Kondo, Youichi Kobayashi, Yuji Hamazaki, Koshiro Sakai, Shigeto Tsukamoto, Ryota Kosaki, and Hiroaki Tsujita
- Subjects
medicine.medical_specialty ,Creatinine ,chemistry.chemical_compound ,chemistry ,business.industry ,Internal medicine ,Cardiology ,medicine ,Myocardial infarction ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease - Published
- 2017
14. Regional calcified plaque score evaluated by multidetector computed tomography for predicting the addition of rotational atherectomy during percutaneous coronary intervention
- Author
-
Youichi Kobayashi, Kyoichi Kaneko, Hiroyuki Yokota, Takehiko Sambe, Masayuki Sakurai, Katsuji Oguchi, Yusuke Kodama, Hui-Ling Li, Hiroaki Tsujita, Shigeto Tsukamoto, Yasushi Akutsu, Atsushi Aoki, Yuji Hamazaki, Koshiro Sakai, Ryota Kosaki, Shinichi Kobayashi, Takehiko Gokan, Naoki Uchida, and Teruo Sekimoto
- Subjects
Target lesion ,Atherectomy, Coronary ,Male ,medicine.medical_specialty ,Computed Tomography Angiography ,medicine.medical_treatment ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Coronary Angiography ,Severity of Illness Index ,030218 nuclear medicine & medical imaging ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Percutaneous Coronary Intervention ,Predictive Value of Tests ,Risk Factors ,Multidetector Computed Tomography ,Odds Ratio ,Medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,cardiovascular diseases ,Angina, Stable ,Vascular Calcification ,Cardiac catheterization ,Computed tomography angiography ,Aged ,Retrospective Studies ,Aged, 80 and over ,Chi-Square Distribution ,Receiver operating characteristic ,medicine.diagnostic_test ,business.industry ,Patient Selection ,Percutaneous coronary intervention ,Middle Aged ,medicine.disease ,Coronary Vessels ,surgical procedures, operative ,Treatment Outcome ,ROC Curve ,Predictive value of tests ,Area Under Curve ,Conventional PCI ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Rotational atherectomy (rotablation) has been proposed as a potentially superior strategy for percutaneous coronary intervention (PCI) in complex and severely calcified lesions.We hypothesized that a per-lesion coronary artery calcium score determined by multidetector computed tomography (MDCT) would be useful for predicting the requriement for rotablation during PCI.MDCT was performed in patients with stable angina pectoris who were scheduled for first PCI. In 116 consecutive subjects (168 target lesions) with successful PCI, MDCT and quantitative coronary angiography (QCA) data were retrospectively evaluated regarding their ability to predict rotablation.PCI without rotablation was performed in 105 patients (154 lesions), and rotablation was added in 11 patients (14 lesions). Patients with rotablation had significantly higher SYNTAX scores (p = 0.007) and total calcium scores (p 0.001) than those without rotablation. Per-lesion, a lesion length ≥20 mm and diameter stenosis ≥74% on QCA as well as a per-lesion calcium score ≥453 and calcification arc ≥270 in MDCT predicted rotablation. After adjustment for potential confounding variables, a high per-lesion calcium score was an independent predictor of rotablation (odds ratio 31.3, 95% confidence interval 2.8-345, p = 0.005, sensitivity 93% and specificity 88%).The extent of target lesion calcification in MDCT, a simple marker of calcified plaque, is useful for predicting the need for rotablation during PCI.
- Published
- 2015
15. Increasing Endothelial Dysfunction Markers Level are Associated with the Incidence of Heart Failure in Patients with Acute Coronary Syndrome
- Author
-
Yoshino Minoura, Youichi Kobayashi, Kosuke Nomura, Hiroaki Tsujita, Seita Kondo, Koshiro Sakai, Ryota Kosaki, Shigeto Tsukamoto, and Yuji Hamazaki
- Subjects
Acute coronary syndrome ,medicine.medical_specialty ,business.industry ,Heart failure ,Internal medicine ,Incidence (epidemiology) ,Cardiology ,Medicine ,In patient ,Endothelial dysfunction ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease - Published
- 2016
16. Dataset of calcified plaque condition in the stenotic coronary artery lesion obtained using multidetector computed tomography to indicate the addition of rotational atherectomy during percutaneous coronary intervention
- Author
-
Teruo Sekimoto, Yasushi Akutsu, Koshiro Sakai, Katsuji Oguchi, Masayuki Sakurai, Hiroaki Tsujita, Ryota Kosaki, Yuji Hamazaki, Hiroyuki Yokota, Yusuke Kodama, Shigeto Tsukamoto, Jumpei Suyama, Kyouichi Kaneko, Takehiko Gokan, Shinichi Kobayashi, Hui-Ling Li, Atsushi Aoki, Youichi Kobayashi, Takehiko Sambe, and Naoki Uchida
- Subjects
Target lesion ,medicine.medical_specialty ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Rotational atherectomy ,lcsh:Computer applications to medicine. Medical informatics ,030218 nuclear medicine & medical imaging ,Percutaneous coronary intervention ,Lesion ,Multidetector computed tomography ,03 medical and health sciences ,0302 clinical medicine ,medicine ,cardiovascular diseases ,lcsh:Science (General) ,Data Article ,Multidisciplinary ,business.industry ,musculoskeletal, neural, and ocular physiology ,nutritional and metabolic diseases ,Coronary artery calcium scores ,CT angiography ,Conventional PCI ,Ecg gating ,cardiovascular system ,lcsh:R858-859.7 ,Radiology ,medicine.symptom ,business ,lcsh:Q1-390 ,Stenotic coronary artery - Abstract
Our data shows the regional coronary artery calcium scores (lesion CAC) on multidetector computed tomography (MDCT) and the cross-section imaging on MDCT angiography (CTA) in the target lesion of the patients with stable angina pectoris who were scheduled for percutaneous coronary intervention (PCI). CAC and CTA data were measured using a 128-slice scanner (Somatom Definition AS+; Siemens Medical Solutions, Forchheim, Germany) before PCI. CAC was measured in a non-contrast-enhanced scan and was quantified using the Calcium Score module of SYNAPSE VINCENT software (Fujifilm Co. Tokyo, Japan) and expressed in Agatston units. CTA were then continued with a contrast-enhanced ECG gating to measure the severity of the calcified plaque condition. We present that both CAC and CTA data are used as a benchmark to consider the addition of rotational atherectomy during PCI to severely calcified plaque lesions. Keywords: Coronary artery calcium scores, Multidetector computed tomography, CT angiography, Rotational atherectomy, Percutaneous coronary intervention
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.